Wegovy

News

Lilly goes toe-to-toe with Novo Nordisk on obesity

Eli Lilly has raised the stakes in its looming battle with Novo Nordisk in the market for obesity drugs, planning a clinical trial that will directly compare its new thera

News

CHMP backs obesity drug Wegovy for teens

Novo Nordisk’s sought-after obesity drug Wegovy could be approved in the EU shortly for use in adolescents as well as adults.

Market Access

Are we entering a new era of blockbuster weight-loss drugs?

Has the industry found a new revenue driver in weight-loss treatments?

News

Sought-after obesity drug Wegovy backed for NHS use

Use is restricted to two years in patients enrolled in NHS weight management services.

News

Amgen to push latecomer obesity drug into midstage testing

Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2

News

Lilly holds off on tirzepatide filing in obesity, waiting fo...

Eli Lilly has decided to wait for the readout of the second of its two phase 3 trials for tirzepatide in obesity, rather than filing on the strength of its first, positive study.

Lilly goes toe-to-toe with Novo Nordisk on obesity

CHMP backs obesity drug Wegovy for teens

Are we entering a new era of blockbuster weight-loss drugs?

Sought-after obesity drug Wegovy backed for NHS use

Amgen to push latecomer obesity drug into midstage testing

Lilly holds off on tirzepatide filing in obesity, waiting fo...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Wegovy

Editor's Picks